Experienced in Hantavirus Infection

Xiaoqing Q. Liu

Union Hospital, 
Wuhan, CN 
Experienced in Hantavirus Infection
Union Hospital, 
Wuhan, CN 
OverviewLocationsClinical Research

Overview

Xiaoqing Liu practices in Wuhan, China. Liu is rated as an Experienced expert by MediFind in the treatment of Hantavirus Infection. Their top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Pure Red Cell Aplasia, Pulmonary Atresia with Ventricular Septal Defect, Vertebroplasty, and Cardiac Ablation.

Their clinical research consists of co-authoring 514 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Hantavirus Infection.

Locations

Union Hospital, Wuhan, 430022, China
Other Locations
No. 300 Guangzhou Road, Nanjing, 210029, China
No. 106 Zhongshan 2nd Road, Guangzhou, 510080, China
321 Zhongshan Road, Nanjing, 210008, China
Xianlin Road 163, Nanjing, 210000, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Effect of Entecavir Treatment on Regression and Long-term Disease Outcome in Patients With HBV-induced Liver Fibrosis and Cirrhosis (Regress Extension Study)
Effect of Entecavir Treatment on Regression and Long-term Disease Outcome in Patients With HBV-induced Liver Fibrosis and Cirrhosis (Regress Extension Study)
Enrollment Status: Unknown
Publish Date: April 28, 2021
Intervention Type: Drug
Study Drug: Entecavir
Study Phase: Phase 4
Optimized Treatment and Regression of HBV-induced Liver Fibrosis
Optimized Treatment and Regression of HBV-induced Liver Fibrosis
Enrollment Status: Completed
Publish Date: July 27, 2018
Intervention Type: Drug
Study Phase: Phase 4
Optimized Treatment and Regression of HBV-induced Early Cirrhosis
Optimized Treatment and Regression of HBV-induced Early Cirrhosis
Enrollment Status: Completed
Publish Date: July 27, 2018
Intervention Type: Drug
Study Phase: Phase 4
Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis
Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis
Enrollment Status: Completed
Publish Date: July 27, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

514 Total Publications

Single-Atom (Sc, V, Cr) Decoration of 1T-TiS2 Monolayers for Gas Sensing of CF4, HF, and SO2: A First-Principles Study.
Single-Atom (Sc, V, Cr) Decoration of 1T-TiS2 Monolayers for Gas Sensing of CF4, HF, and SO2: A First-Principles Study.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: December 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Liu's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 86 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile